DELCATH SYSTEMS, INC. — Director's Dealing 2024

Nov 1, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DELCATH SYSTEMS, INC. (DCTH)
CIK: 0000872912
Period of Report: 2024-10-30

Reporting Person: Aharon Gil (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-10-30	Tranche B warrants to purchase F-4 Preferred Stock	$1000	M	500	Acquired		F-4 PREFERRED STOCK (500)	Indirect
2024-10-30	8% CONVERTIBLE NOTE	$0	H	0	Acquired		CASH ()	Indirect

Footnotes

F1: Immediately exercisable

F2: The Tranche B Warrants expire the earlier of (i) twenty-one (21) days following the date of the Issuer's public announcement of record at least $10,000,000 in quarterly U.S. revenue from the commercialization of HEPZATO and (ii) March 31, 2026. The Issuer announced on October 17, 2024 that it had recorded at least $10,000,000 in quarterly U.S. revenue from the commercialization of HEPZATO and therefore such Tranche B Warrants expire on November 7, 2024.

F3: Reporting Persons disclaims beneficial ownership over the shares except to the extent of his or its respective pecuniary interest therein

F4: N/A

F5: Delcath repaid the DELCATH SYSTEM - 8% CONVERTIBLE NOTE in full with cash of $1,423,333.